Idris Guessous to Prevalence
This is a "connection" page, showing publications Idris Guessous has written about Prevalence.
Connection Strength
0.231
-
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021 06 08; 12(1):3455.
Score: 0.047
-
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319.
Score: 0.044
-
Organised population-based programmes and change in socioeconomic inequalities in mammography screening: A 1992-2012 nationwide quasi-experimental study. Prev Med. 2018 11; 116:19-26.
Score: 0.039
-
Public smoking ban and socioeconomic inequalities in smoking prevalence and cessation: a cross-sectional population-based study in Geneva, Switzerland (1995-2014). Tob Control. 2018 11; 27(6):663-669.
Score: 0.037
-
Introduction of an organised programme and social inequalities in mammography screening: A 22-year population-based study in Geneva, Switzerland. Prev Med. 2017 Oct; 103:49-55.
Score: 0.036
-
Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting. Ann Intern Med. 2021 09; 174(9):1252-1260.
Score: 0.012
-
Associations of sodium, potassium and protein intake with blood pressure and hypertension in Switzerland. Swiss Med Wkly. 2017; 147:w14411.
Score: 0.009
-
Chronic symptoms in a representative sample of community-dwelling older people: a cross-sectional study in Switzerland. BMJ Open. 2017 01 17; 7(1):e014485.
Score: 0.009